Kamunting Street Capital Management, L.P. Ocular Therapeutix, Inc Call Options Transaction History

Kamunting Street Capital Management, L.P.

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2021 Nov 15, 2021	BUY	$9.7 - $14.34 $3,404 - $5,033	351 New	351 $351,000
Q3 2019 Nov 14, 2019	SELL	$3.04 - $5.32 $228,000 - $399,000	-75,000 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$2.46 - $4.52 $184,500 - $338,999	75,000 New	75,000 $330,000

171

138M

150K

225K

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $654M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

Get notified when there are updates to the investment portfolio of Kamunting Street Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Kamunting Street Capital Management, L.P. with notifications on news.